Chemiluminescence reagent for western blotting
Chemiluminescence reagent for Western blotting is a laboratory product designed to facilitate the detection and quantification of proteins in Western blot analysis. The reagent generates a luminescent signal upon reaction with the enzyme-labeled antibodies used in the Western blotting technique, allowing for the visualization and analysis of target proteins.
Lab products found in correlation
6 protocols using chemiluminescence reagent for western blotting
Estrogen Receptor Signaling Protocol
Evaluation of Estrogen Receptor and Ubiquitin in BT-474 and MDA-MB-231 Cells
Breast Cancer Cell Line Characterization
Estrogen Receptor Signaling Pathway Protocol
Breast and Cervical Cancer Cell Culture
17β-estradiol (E2), epidermal growth factor (EGF), 4OH-tamoxifen (Tam), DMEM (with and without phenol red), fetal calf serum, charcoal stripped fetal calf serum (DCC) and the palmitoylacyl-transferase (PAT) inhibitor 2-bromohexadecanoic acid (2-bromo-palmitate; 2-Br) [IC 50 of ~4 µM] (Varner et al., 2003) were purchased from Sigma-Aldrich (St. Louis, MO). Bradford protein assay kit as well as anti-mouse and anti-rabbit secondary antibodies were obtained from Bio-Rad (Hercules, CA). Antibodies against ERα (F-10 mouse -for WB), pS2 (FL-84 rabbit) and cathepsin D (H75 rabbit) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA); anti-vinculin antibody was from Sigma-Aldrich (St. Louis, MO). All other antibodies were purchased by Cell Signalling Technology Inc. (Beverly, MA, USA). Chemiluminescence reagent for Western blotting was obtained from BioRad Laboratories (Hercules, CA, USA). Nano-Glo® Endurazine TM was purchased from Promega (Promega, Madison, MA, USA). All the other products were from Sigma-Aldrich. Analytical-or reagent-grade products were used without further purification. The identities of all the used cell lines [i.e., human breast carcinoma cells (MCF-7 and T47D-1) and human cervix carcinoma cells (HeLa)] were verified by STR analysis (BMR Genomics, Italy).
Estrogen Signaling in Breast Cancer
17β-estradiol, DMEM (with and without phenol red) and fetal calf serum were purchased from Sigma-Aldrich (St. Louis, MO). Bradford protein assay kit as well as anti-mouse and antirabbit secondary antibodies were obtained from Bio-Rad (Hercules, CA). Antibodies against ERα (F-10 mouse), cyclin D1 (H-295 rabbit), cathepsin D (H75 rabbit), pS2 (FL-84 rabbit), were obtained from Santa Cruz Biotechnology (Santa Cruz, CA); anti-vinculin antibody was from Sigma-Aldrich (St. Louis, MO). Chemiluminescence reagent for Western blotting was obtained from BioRad Laboratories (Hercules, CA, USA). Faslodex (i.e., fulvestrant or ICI182,780) and 4OH-tamoxifen were purchased by Tocris (USA). FDA-approved drug library was purchased by Selleck Chemicals (USA). All the other products were from Sigma-Aldrich. Analytical-or reagentgrade products were used without further purification. The identities of all of the used cell lines [i.e., human breast carcinoma cells (MCF-7; ZR-75-1)] were verified by STR analysis (BMR Genomics, Italy).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!